نتایج جستجو برای: dlbcl

تعداد نتایج: 2906  

Journal: :Oncology reports 2012
Hiroki Nishikawa Mitsuru Tsudo Yukio Osaki

Clinical outcome of diffuse large B-cell lymphoma (DLBCL) patients with hepatitis C virus (HCV) infection in the rituximab era remains unclear. The aim of the present study was to compare the clinical outcome, treatment response and hepatotoxicity in DLBCL patients who received rituximab containing immunochemotherapy that had HCV infection and tho...

2014
Joong-Keun Kim Joo-Seop Chung Ho-Jin Shin Moo-Kon Song Ji-Won Yi Dong-Hun Shin Dae-Sung Lee Sung-Min Baek

BACKGROUND Although adding rituximab to the chemotherapy regimen of cyclophosphamide, vincristine, doxorubicin, and prednisone (R-CHOP) has improved clinical outcomes of patients with diffuse large B-cell lymphoma (DLBCL), several recent studies have shown that the effect of rituximab is dominantly in the non-germinal center (non-GC) subtype compared to the germinal center (GC) subtype. Natural...

2016
Yinghan Su Bin Sun Xuejing Lin Xinying Zhao Weidan Ji Miaoxia He Haihua Qian Xianmin Song Jianmin Yang Jianmin Wang Jie Chen

In diffuse large B-cell lymphoma (DLBCL), many oncogenic microRNAs (OncomiRs) are highly expressed to promote disease development and progression by inhibiting the expression and function of certain tumor suppressor genes, and these OncomiRs comprise a promising new class of molecular targets for the treatment of DLBCL. However, most current therapeutic studies have focused on a single miRNA, w...

Journal: :Blood 2012
Karen E Deffenbacher Javeed Iqbal Warren Sanger Yulei Shen Cynthia Lachel Zhongfeng Liu Yanyan Liu Megan S Lim Sherrie L Perkins Kai Fu Lynette Smith James Lynch Louis M Staudt Lisa M Rimsza Elaine Jaffe Andreas Rosenwald German K Ott Jan Delabie Elias Campo Randy D Gascoyne Mitchell S Cairo Dennis D Weisenburger Timothy C Greiner Thomas G Gross Wing C Chan

Burkitt lymphoma (BL) predominates in pediatric patients, whereas diffuse large B-cell lymphoma (DLBCL) is uncommon. In contrast to adults, BL and DLBCL are treated similarly in children and both entities have superior outcomes in children compared with adults. Gene expression profiling (GEP) and miRNA expression profiling clearly differentiated pediatric DLBCL from BL, forming distinct cluster...

Journal: :Blood 2005
Stefano Monti Kerry J Savage Jeffery L Kutok Friedrich Feuerhake Paul Kurtin Martin Mihm Bingyan Wu Laura Pasqualucci Donna Neuberg Ricardo C T Aguiar Paola Dal Cin Christine Ladd Geraldine S Pinkus Gilles Salles Nancy Lee Harris Riccardo Dalla-Favera Thomas M Habermann Jon C Aster Todd R Golub Margaret A Shipp

Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease with recognized variability in clinical outcome, genetic features, and cells of origin. To date, transcriptional profiling has been used to highlight similarities between DLBCL tumor cells and normal B-cell subtypes and associate genes and pathways with unfavorable outcome. To identify robust and highly reproducible DL-BCL subtype...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Bernhard Kloo Daniel Nagel Matthias Pfeifer Michael Grau Michael Düwel Michelle Vincendeau Bernd Dörken Peter Lenz Georg Lenz Daniel Krappmann

The activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) represents a very aggressive human lymphoma entity. Constitutive NF-κB activation caused by chronic active B-cell receptor (BCR) signaling is common feature of many ABC DLBCL cells; however, the pathways linking BCR signaling to the NF-κB prosurvival network are largely unknown. Here we report that constitutive act...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2004
S Wöhrer A Püspök J Drach M Hejna A Chott M Raderer

BACKGROUND Diffuse large B-cell lymphoma (DLBCL) of the stomach is a relatively common disease. Recently, chemotherapy consisting of doxorubicin, cyclophosphamide, vincristine and prednisone (CHOP) has been reported as effective treatment for early-stage gastric DLBCL. Given the fact that the application of the CD20 antibody rituximab (R) in addition to CHOP has improved outcomes in nodal DLBCL...

2014
Matthew A. Care Mario Cocco Jon P. Laye Nicholas Barnes Yuanxue Huang Ming Wang Sharon Barrans Ming Du Andrew Jack David R. Westhead Gina M. Doody Reuben M. Tooze

Interferon regulatory factor 4 (IRF4) is central to the transcriptional network of activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL), an aggressive lymphoma subgroup defined by gene expression profiling. Since cofactor association modifies transcriptional regulatory input by IRF4, we assessed genome occupancy by IRF4 and endogenous cofactors in ABC-DLBCL cell lines. IRF4 partners ...

Journal: :[Rinsho ketsueki] The Japanese journal of clinical hematology 2012
Masafumi Taniwaki

Diffuse large B-cell lymphoma (DLBCL) is the most common form of lymphoma in adults. The disease exhibits a striking heterogeneity in gene expression profiles and clinical outcomes, but its genetic causes remain to be fully defined. Through whole genome and exome sequencing, we characterized the genetic diversity of DLBCL. In all, we sequenced 73 DLBCL primary tumors (34 with matched normal DNA...

2017
Akashi Fujita Masahiro Tajika Tsutomu Tanaka Makoto Ishihara Yutaka Hirayama Nobumasa Mizuno Kazuo Hara Susumu Hijioka Hiroshi Imaoka Tsukasa Yoshida Nozomi Okuno Nobuhiro Hieda Takashi Hirayama Hitoshi Shibuya Hisashi Kondo Hirotaka Suzuki Kazuhiro Toriyama Yasushi Yatabe Kenji Yamao Yasumasa Niwa

API2-MALT1 translocation-positive gastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT) lymphoma is thought to transform to diffuse large B-cell lymphoma (DLBCL) rarely. A 69-year-old man presented with epigastralgia. Esophagogastroduodenoscopy showed multiple ulcerations in the stomach. Endoscopic biopsies revealed MALT lymphoma, with Helicobacter pylori infection. The pa...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید